Combination of Toripalimab and JS004 Therapy for ccRCC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Clear Cell Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE3
68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC
- Status
- SUSPENDED
- Phase
- PHASE1
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
- Status
- RECRUITING
- Phase
- PHASE2
A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study
- Status
- COMPLETED
- Phase
- N/A
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Phase 1/2 Trial of ADI-270 in ccRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of MGC026 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
- Status
- COMPLETED
- Phase
- PHASE2
89Zr-DFO-girentuximab Expanded Access Program (EAP)
- Status
- AVAILABLE
- Phase
- N/A
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
- Status
- RECRUITING
- Phase
- N/A
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
- Status
- TERMINATED
- Phase
- PHASE2
68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
- Status
- UNKNOWN
- Phase
- PHASE2
68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion
- Status
- UNKNOWN
- Phase
- PHASE2